Nuwellis decoration

Newsroom

Newsroom

Press Releases

Date Title and Summary Additional Formats
January 9, 2023
Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
MINNEAPOLIS , Jan. 09, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced preliminary unaudited results for fourth quarter and full year 2022.
January 5, 2023
Nuwellis Appoints Dr. John Jefferies as Chief Medical Officer
Dr. Jefferies brings over two decades of cardiology and heart failure expertise to Nuwellis as the Company expands clinical evidence supporting the use of ultrafiltration for people with fluid overload MINNEAPOLIS , Jan. 05, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc.
January 4, 2023
Nuwellis, Inc. Announces Passage of Warrant Proposal
MINNEAPOLIS , Jan. 04, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that the Company held its adjourned special meeting of stockholders on January 4, 2023 at 2:00 p.m.

Upcoming Events

More events are coming soon.
jump